Clinical Trial Update: Clinician Attitudes and Behaviors Regarding Use of Pre-Exposure Prophylaxis (PrEP) for Primary HIV Prevention

View source ↗

Summary

This completed clinical trial reports on clinician attitudes and behaviors regarding the use of pre-exposure prophylaxis (PrEP) for primary HIV prevention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Clinician Attitudes About PrEP | Status: COMPLETED